Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma-Reference-Cited by-同舟云学术

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma

Published:2009-12-15 Issue:24 Volume:115 Page:5828-5835
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Katzenstein Howard M.,Chang Kay W.,Krailo Mark,Chen Zhengjia,Finegold Milton J.,Rowland Jon,Reynolds Marleta,Pappo Alberto,London Wendy B.,Malogolowkin Marcio,

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24667/fullpdf

Reference20 articles.

1. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study;Douglass;J Clin Oncol.,1993

2. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group;Ortega;J Clin Oncol.,1991

3. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma;Cheung;J Clin Oncol.,1991

4. Treatment of unresectable and metastatic hepatoblastoma: a Pediatric Oncology Group phase II study;Katzenstein;J Clin Oncol.,2002

5. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study;Dall'Igna;Med Pediatr Oncol.,2001

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children’s hepatic tumors international collaboration database;eClinicalMedicine;2024-10

2. Association of Sociodemographic Factors with Surgical Management of Hepatoblastoma and Hepatocellular Carcinoma in Children;The Journal of Pediatrics;2024-06

3. Cisplatin and ototoxicity in childhood: the perspective of supporting otoprotective agentes;Brazilian Journal of Biology;2024

4. Children's Oncology Group's 2023 blueprint for research: Liver tumors;Pediatric Blood & Cancer;2023-07-26

5. Systematic Review and Meta‐analysis of the Influence of Genetic Variation on Ototoxicity in Platinum‐Based Chemotherapy;Otolaryngology–Head and Neck Surgery;2023-02-17